UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000032405
Receipt number R000036957
Scientific Title Utility of the TKA postoperative additional nerve block
Date of disclosure of the study information 2018/05/01
Last modified on 2019/04/29 09:19:40

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Utility of the TKA postoperative additional nerve block

Acronym

Utility of the TKA postoperative additional nerve block

Scientific Title

Utility of the TKA postoperative additional nerve block

Scientific Title:Acronym

Utility of the TKA postoperative additional nerve block

Region

Japan


Condition

Condition

Osteoarthritis of the knee joint

Classification by specialty

Orthopedics

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

We consider whether a postoperative additional nerve block is useful for TKA postoperative pain management

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Pain VAS (0, 3, 6, 9, 12, 24, 36, 48h)
Postoperative pain-killer use
The days required for SLR
Change of the knee flexion angle
Frequency of the adverse event

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Single blind -participants are blinded

Control

Placebo

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Medicine Maneuver

Interventions/Control_1

additional femoral nerve block

20 ml of 0.25% levobupivacaine
is injected from an indwelling catheter
two days after surgery

Interventions/Control_2

no additional femoral nerve block

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

50 years-old <=

Age-upper limit

90 years-old >

Gender

Male and Female

Key inclusion criteria

OA knee joint planning primary TKA

Key exclusion criteria

simultaneous bilateral case
the case with the limit for medication

Target sample size

80


Research contact person

Name of lead principal investigator

1st name Tomohiro
Middle name
Last name Ojima

Organization

Fukui General Hospital

Division name

Dept. of Orthopaedic Surgery

Zip code

9108561

Address

58-16-1, Egami, Fukui

TEL

0776-59-1300

Email

ojima@ka2.so-net.ne.jp


Public contact

Name of contact person

1st name Tomohiro
Middle name
Last name Ojima

Organization

Fukui General Hospital

Division name

Dept. of Orthopaedic Surgery

Zip code

9108561

Address

58-16-1, Egami, Fukui

TEL

0776-59-1300

Homepage URL


Email

ojima@ka2.so-net.ne.jp


Sponsor or person

Institute

Fukui General Hospital

Institute

Department

Personal name



Funding Source

Organization

Fukui General Hospital

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Fukui General Hospital

Address

58-16-1, Egami, Fukui

Tel

0776-59-1300

Email

ojima@ka2.so-net.ne.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2018 Year 05 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

100

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2018 Year 01 Month 01 Day

Date of IRB

2018 Year 04 Month 01 Day

Anticipated trial start date

2018 Year 04 Month 01 Day

Last follow-up date

2019 Year 04 Month 29 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2018 Year 04 Month 27 Day

Last modified on

2019 Year 04 Month 29 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000036957


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name